A McGill University-led clinical trial is the first in humans to show online brain training exercises can improve brain networks affecting learning and memory.
The study found 10 weeks’ use of the game-like app BrainHQ by older adults enhanced cholinergic function, a chemical system in the brain that typically declines with age and influences attention, memory and decision-making.
McGill University researchers have engineered a new hydrogel that shows early promise as a treatment for people with vocal cord injuries.
Voice loss is often permanent when scarring forms on the vocal cords. Current injectable treatments break down quickly, which can force patients to get repeated procedures that can further damage the delicate tissue.
Thirty-two McGill research projects have received new funding from the Canada Foundation for Innovation's for investments in research infrastructure to support their innovative projects, for a total federal investment of $9.7 million.
McGill University researchers have engineered a new hydrogel that shows early promise as a treatment for people with vocal cord injuries.
Voice loss is often permanent when scarring forms on the vocal cords. Current injectable treatments break down quickly, which can force patients to get repeated procedures that can further damage the delicate tissue.
Researchers at McGill’s Centre of Genomics and Policy (CGP) have launched a first-of-its-kind guide to help Canadian health-care providers offer more inclusive, respectful and affirming care to intersex adults.
McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.
In a study published in Nature Communications, the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.
Jérôme Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.
The McGill researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years.
Access to respite services for family caregivers increases a palliative care patient’s probability of dying at home almost threefold, according to a McGill University-led study.
Previous surveys suggest most Canadians with a serious illness would prefer to spend the end of their lives at home. In Quebec, fewer than one-in-10 palliative care patients die at home, a rate that has remained largely unchanged for two decades and lags behind the Canadian average of 15 per cent.
Claire M. Brown, Professor in the Department of Physiology, has been selected as Chair for Inclusion in Science and Engineering (CISE) in the province of Quebec. The newly established CISE program is jointly funded by the Natural Sciences and Engineering Research Council (NSERC) and the Fonds de recherche du Québec – Nature et technologies (FRQNT).
Survivors of sexual assault in largely rural and remote Northwestern Ontario face systemic barriers when seeking forensic care, according to a new study led by McGill University researchers.
Join D2R for this hybrid seminar with Professor Eric Westhof from University of Strasbourg
Researchers at McGill University and the Douglas Institute have identified two specific types of brain cells that are altered in people with depression.
The study, published in Nature Genetics, opens the door to developing new treatments that target these cells and deepens our understanding of depression, a leading cause of disability worldwide that affects more than 264 million people.
D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative’s strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.
This competition is open to:
Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).
